Ulrich Reinhold Speck
Chief Tech/Sci/R&D Officer at ACOTEC SCIENTIFIC HOLDINGS LIMITED
Ulrich Reinhold Speck active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ACOTEC SCIENTIFIC HOLDINGS LIMITED | Chief Tech/Sci/R&D Officer | 2021-01-28 | - |
Career history of Ulrich Reinhold Speck
Former positions of Ulrich Reinhold Speck
| Companies | Position | Start | End |
|---|---|---|---|
InnoRa GmbH
 InnoRa GmbH Medical/Nursing ServicesHealth Services InnoRa GmbH is a German company that specializes in randomized clinical trials and contributions to product development. The private company is based in Berlin, Germany. The company focuses on developing coated balloons, devices, and therapeutics for restenosis inhibition by non-stent-based local drug delivery. In addition, they conduct clinical trials and research in pharmacology, pharmacokinetics, bioanalytics, relaxometry, and molecular imaging. The company was founded in 2001 by Ulrich Reinhold Speck. Thomas Speck has been the CEO of the company since 2011. | Founder | 2000-12-31 | 2017-01-17 |
| General Counsel | 2002-01-13 | 2017-01-17 | |
| Charité - Universitätsmedizin Berlin | Corporate Officer/Principal | 1999-12-31 | 2000-12-31 |
Training of Ulrich Reinhold Speck
| Freie Universität Berlin | Doctorate Degree |
Statistics
International
| Germany | 4 |
| Cayman Islands | 2 |
Operational
| Founder | 1 |
| General Counsel | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Consumer Services | 3 |
| Health Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ACOTEC SCIENTIFIC HOLDINGS LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
InnoRa GmbH
InnoRa GmbH Medical/Nursing ServicesHealth Services InnoRa GmbH is a German company that specializes in randomized clinical trials and contributions to product development. The private company is based in Berlin, Germany. The company focuses on developing coated balloons, devices, and therapeutics for restenosis inhibition by non-stent-based local drug delivery. In addition, they conduct clinical trials and research in pharmacology, pharmacokinetics, bioanalytics, relaxometry, and molecular imaging. The company was founded in 2001 by Ulrich Reinhold Speck. Thomas Speck has been the CEO of the company since 2011. | Health Services |
